International Journal of Prosthodontics and Restorative Dentistry

Register      Login

VOLUME 2 , ISSUE 4 ( October-December, 2012 ) > List of Articles

RESEARCH ARTICLE

Evaluation of Hemocompatibility of Titanium after Various Surface Treatments: An in vitro Study

Yemineni BhavanChand, R Ranzani, H Annapoorani

Citation Information : BhavanChand Y, Ranzani R, Annapoorani H. Evaluation of Hemocompatibility of Titanium after Various Surface Treatments: An in vitro Study. Int J Prosthodont Restor Dent 2012; 2 (4):136-142.

DOI: 10.5005/jp-journals-10019-1062

Published Online: 01-09-2015

Copyright Statement:  Copyright © 2012; The Author(s).


Abstract

Objective

To evaluate the hemocompatibility of titanium after various surface treatments.

Materials and methods

A total of 27 disk-shaped specimens (3 ⨯ 10.0 mm) were prepared from a cylindrical rod of medical grade titanium. The disks were divided into three groups, of which one was considered as the control (mechanical surface polished surface). The other groups being sandblasted disks and anodized disks. Surface evaluation was done for sandblasted and anodized disks with scanning electron microscope. The specimens were placed in polystyrene culture plates and agitated with phosphate buffered saline for 5 minutes before they were exposed to blood taken from human volunteer. The materials were under 30 minutes agitation at 75 ± 5 rpm using an Environ shaker thermostated at 35 ± 20°C. The total hemoglobin from the initial sample was measured using automatic hematology analyzer. Percentage hemolysis, thrombin time, platelet adhesion and activation were assessed. Significant differences between different treated titanium materials were determined using Minitab® Version 15.1.1.0. A two-sample t-test was performed to find the p-values for different groups of data.

Results

After 30 minutes of agitation, cells began to spread on the test surfaces. There was a clear reduction in the number of platelets before and after exposure to titanium samples. Reduction of leukocytes was seen to a least extent on the anodized surface. Rough surface induced higher hemolysis than other groups. Platelet reduction and leukocyte reduction in all the three surfaces was quite higher than that obtained for reference plate. Surface variation has no significance on the thrombogenic capabilities of medical grade titanium (p < 0.05).

Significance

The hemocompatibility of medical grade titanium did not vary with different surface modifications.

How to cite this article

BhavanChand Y, Ranzani R, Annapoorani H. Evaluation of Hemocompatibility of Titanium after Various Surface Treatments: An in vitro Study. Int J Prosthodont Restor Dent 2012;2(4):136-142.


PDF Share
  1. Substitute heart valves: Do we need better ones? Biomater Forum 1996;18(5):14-16.
  2. Stratagem report to the natural science discipline development: Biomedical engineering. Beijing: Scientific Press 1995:88.
  3. Biocompatibility of titanium implants: Surface science aspects. J Prosthet Dent 1983;49(6):832-37.
  4. In vitro investigation of blood compatibility of Ti with oxide layer of rutile structure. J Biomater Appl 1994;8:404-12.
  5. Titanium-protein interaction: Change with oxide layer thickness. J Biomater Appl 1991;5(6):89-98.
  6. Ceramic as material for cardiovascular device, World Congress on Medical Physics and Biomedical Engineering, Hamburg 1982;3:7.
  7. Blood compatibility of amorphous titanium oxide films synthesized by ion beam enhanced deposition. Biomaterials 1998;19:771-76.
  8. Artificial heart valves: Improved hemocompatibility by titanium oxide coatings prepared by ion beam assisted deposition. Surf Coat Technol 1998;103-4:146-50.
  9. Surface modification of titanium, titanium alloys, and related materials for biomedical applications. Mat Sci Eng 2004;47:49-121.
  10. A histomorphometric analysis of the effects of various surface treatment methods on osseointegration. Int J Oral Maxillofac Implants 2003;18:349-56.
  11. Ion implantation: Surface treatment for improving the bone integration of titanium and Ti6Al4V dental implants. Clin Oral Implants Res 2003;14:57-62.
  12. Surface treatments of titanium implants. Eur Cells Mat 2003;5:32-33.
  13. Anodized Ti and Ti6Al4V possessing nanosurface features enhances osteoblast adhesion. J Biomed Nanotechnol 2005;1:68-73.
  14. Enhanced osteoblast adhesion to drug-coated anodized nanotubular titanium surfaces. Int J Nanomed 2008;3:257-64.
  15. Transparent highly ordered TiO2 nanotube arrays via anodization of titanium thin films. Adv Funct Mater 2005;15:1291-96.
  16. Complement driven by conformational changes. Nat Rev Immunol 2008;8:48-58.
  17. C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997;89:2863-70.
  18. Complement diagnostics, haemocompatibility testing of medical devices, pharmaceuticals and blood products; TECO Medical Group brochure.
  19. The use of the Chandler loop to examine the interaction potential of NXY-059 on the thrombolytic properties of rtPA on human thrombi in vitro. Br J Pharmacol 2008;153:124-31.
  20. The Aachen miniaturized heart-lung machine—first results in a small animal model. Artif Organs 2009;33(11):935-40.
  21. Surface modification of titanium, titanium alloys, and related materials for biomedical applications. Mater Sci Eng R 2004;47:49-121.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.